Clinuvel Pharmaceuticals Limited
CLVLF
$7.96
-$0.1583-1.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.16% | 22.09% | 17.54% | 14.03% | 24.35% |
| Total Receivables | 13.08% | 33.83% | 18.40% | 14.86% | 22.96% |
| Inventory | -32.00% | -19.52% | 11.91% | 8.56% | 182.27% |
| Prepaid Expenses | 134.23% | 177.22% | -- | -- | 44.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 24.64% | 20.90% | -- |
| Total Current Assets | 2.53% | 21.35% | 17.40% | 13.89% | 28.87% |
|
|
|||||
| Total Current Assets | 2.53% | 21.35% | 17.40% | 13.89% | 28.87% |
| Net Property, Plant & Equipment | -18.20% | -3.19% | 171.44% | 163.31% | 212.99% |
| Long-term Investments | -- | -- | -- | -- | 0.24% |
| Goodwill | -- | -- | -- | -- | 0.24% |
| Total Other Intangibles | -- | -- | 0.32% | -2.74% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -47.83% | -38.26% | -3.46% | -6.35% | 175.40% |
| Total Assets | 1.30% | 19.89% | 19.61% | 16.03% | 32.45% |
|
|
|||||
| Total Accounts Payable | -20.88% | -6.36% | -15.78% | -18.30% | 52.32% |
| Total Accrued Expenses | 2.82% | 21.70% | 30.10% | 26.20% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.82% | 17.38% | 23.28% | 19.58% | 10.63% |
| Total Finance Division Other Current Liabilities | -77.61% | -73.50% | -1.37% | -4.32% | 58.03% |
| Total Other Current Liabilities | -77.61% | -73.50% | -1.37% | -4.32% | 58.03% |
| Total Current Liabilities | -59.52% | -52.09% | -0.86% | -3.83% | 65.36% |
|
|
|||||
| Total Current Liabilities | -59.52% | -52.09% | -0.86% | -3.83% | 65.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -58.40% | -50.77% | -26.87% | -29.06% | -12.05% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 69.45% | 100.54% | -17.06% | -19.54% | 18.30% |
| Total Liabilities | -48.05% | -38.51% | -3.10% | -6.00% | 56.84% |
|
|
|||||
| Common Stock & APIC | -9.75% | 6.81% | 11.44% | 8.11% | 11.99% |
| Retained Earnings | 616.44% | 747.93% | 407.31% | 398.12% | 118.21% |
| Treasury Stock & Other | 71.04% | 102.43% | -81.13% | -81.70% | -76.45% |
| Total Common Equity | 10.43% | 30.69% | 23.62% | 19.92% | 28.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.43% | 30.69% | 23.62% | 19.92% | 28.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.43% | 30.69% | 23.62% | 19.92% | 28.74% |
|
|
|||||